Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Medical Legal
OIG and Justice Department Investigating Certain Blood Testing Labs for…
We outlined a special fraud alert that targeted the relationship between blood-testing laboratories and physicians. In…
OIG Releases Special Fraud Alert: Laboratory Payments to Referring…
Many physicians and other healthcare providers refer a high volume of patient specimens to third party clinical…
D.C. Circuit Court Reaffirms Attorney-Client Privilege in Internal…
As reported by the law firm Husch Blackwell, a recent D.C. Circuit court decision reaffirms that the attorney-client privilege…
Celgene Faces Off-Label Promotion Lawsuit Over Successful Cancer Drugs…
Since 2006, Celgene Corporation has earned $20.9 billion from the sales of two of its drugs—Thalomid and Revlimid. The drugs are…
Antitrust Lawsuit Against Celgene Over Thalomid and Revlimid Focuses on…
Celgene's successful cancer drugs Thalomid and Revlimid are at the center of an antitrust action. On April 3rd, Mylan…
GSK Settles for $105 Million Under State Consumer Protection Laws; Agrees…
GlaxoSmithKline reached a $105 million settlement with 44 states and D.C. to resolve allegations that the company unlawfully…
Compliance Challenges within Medical Affairs
Last week's World Congress Second Annual Summit on The Evolving Role of Medical Affairs and Thought Leader Engagement in…
Supreme Court Declines to Review Important False Claims Act Issue
In our February article, Will Sunshine Data Help Qui Tam Whistleblowers and Their Attorneys?, we mentioned that while…
Qui Tam Lawyers Mining the Medicare Database for Potential Fraud
The press had a field day with the newly released Medicare payment data. We recently discussed the fact that many of these news…
Takeda, Lilly Hit with $9 Billion Punitive Damages in Actos Lawsuit
Asia's biggest pharmaceutical company, Takeda, and their marketing partner, Eli Lilly, face $9 billion in punitive damages…